Co-Authors
This is a "connection" page, showing publications co-authored by Christopher Butler and Jienchi Dorward.
Connection Strength
1.740
-
The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: a rapid review. Antivir Ther. 2020; 25(7):365-376.
Score: 0.860
-
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med. 2021 09; 9(9):1010-1020.
Score: 0.240
-
Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS. 2021 03 15; 35(4):F1-F10.
Score: 0.234
-
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis. Lancet HIV. 2021 03; 8(3):e158-e165.
Score: 0.232
-
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021 09 04; 398(10303):843-855.
Score: 0.060
-
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk. BMJ Open. 2021 06 18; 11(6):e046799.
Score: 0.059
-
The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms. JMIR Public Health Surveill. 2020 07 02; 6(3):e19773.
Score: 0.056